Stage | V.V (%) | Recurrent V.V. (%) | SVT (%) | DVT (%) | PE (%) | Ulceration (%) | Vulval/cross-pelvic collaterals (%) | Swelling (%) | Claudication (%) |
Stage 1 (n = 17) | 100 | 3 | 3 | 0 | 3 | 3 | 0 | 0 | 0 |
Stage 2 (n = 15) | 93 | 20 | 20 | 6 | 0 | 0 | 6 | 6 | 6 |
Stage 3 (n = 7) | 100 | 0 | 14 | 14 | 0 | 14 | 0 | 100 | 71 |
Stage 4a (n = 14) | 7 | 7 | 7 | 93 | 0 | 0 | 28.6 | 85.7 | 93 |
Stage 4b (n = 8) | 25 | 25 | 100 | 100 | 37.5 | 0 | 12.5 | 8 | 100 |